Progyny Other Liab vs Current Deferred Revenue Analysis
PGNY Stock | USD 28.09 0.54 1.96% |
Progyny financial indicator trend analysis is much more than just breaking down Progyny prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Progyny is a good investment. Please check the relationship between Progyny Other Liab and its Current Deferred Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.
Other Liab vs Current Deferred Revenue
Other Liab vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Progyny Other Liab account and Current Deferred Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Progyny's Other Liab and Current Deferred Revenue is -0.56. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Progyny, assuming nothing else is changed. The correlation between historical values of Progyny's Other Liab and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Progyny are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Other Liab i.e., Progyny's Other Liab and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | -0.56 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Other Liab
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from Progyny's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Progyny current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.At this time, Progyny's Tax Provision is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 59 M in 2024.
2023 | 2024 (projected) | Discontinued Operations | 6.6M | 7.0M | Interest Income | 732.6K | 421.8K |
Progyny fundamental ratios Correlations
Click cells to compare fundamentals
Progyny Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Progyny fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 150.4M | 253.9M | 358.1M | 543.0M | 756.6M | 794.5M | |
Other Current Liab | 16.8M | 34.3M | 2.2M | 49.0M | 1.2M | 1.1M | |
Total Current Liabilities | 36.2M | 77.8M | 98.8M | 159.5M | 186.0M | 95.3M | |
Total Stockholder Equity | 114.3M | 166.9M | 251.8M | 377.0M | 553.4M | 581.1M | |
Net Tangible Assets | 100.0M | 153.9M | 239.3M | 365.0M | 419.7M | 440.7M | |
Property Plant And Equipment Net | 3.1M | 12.1M | 12.8M | 15.3M | 27.8M | 29.2M | |
Net Debt | (80.4M) | (62.0M) | (84.0M) | (112.4M) | (77.9M) | (81.8M) | |
Retained Earnings | (113.5M) | (68.2M) | (2.4M) | 27.9M | 90.0M | 94.5M | |
Accounts Payable | 19.4M | 43.5M | 61.4M | 109.3M | 125.4M | 131.7M | |
Cash | 80.4M | 70.3M | 91.4M | 120.1M | 97.3M | 73.0M | |
Non Current Assets Total | 18.0M | 63.7M | 99.5M | 109.1M | 116.2M | 69.4M | |
Non Currrent Assets Other | 652K | 573K | 2.9M | 4.0M | 3.4M | 1.9M | |
Other Assets | 652K | 8.2M | 74.2M | 81.9M | 94.2M | 98.9M | |
Cash And Short Term Investments | 80.4M | 109.3M | 119.4M | 189.3M | 371.1M | 389.6M | |
Net Receivables | 47.1M | 75.7M | 134.6M | 240.1M | 241.9M | 121.6M | |
Common Stock Shares Outstanding | 83.6M | 99.1M | 100.4M | 100.0M | 100.7M | 101.6M | |
Liabilities And Stockholders Equity | 150.4M | 253.9M | 358.1M | 543.0M | 756.6M | 794.5M | |
Non Current Liabilities Total | 19.4M | 9.2M | 7.4M | 6.5M | 17.2M | 10.4M | |
Capital Surpluse | 228.8M | 236.1M | 255.3M | 349.5M | 402.0M | 422.1M | |
Other Current Assets | 5.0M | 5.3M | 4.6M | 4.5M | 27.5M | 28.8M | |
Other Stockholder Equity | 227.7M | 235.1M | 254.3M | 348.5M | 460.6M | 242.6M | |
Total Liab | 36.2M | 87.0M | 106.2M | 166.0M | 203.2M | 102.6M | |
Net Invested Capital | 114.3M | 166.9M | 251.8M | 377.0M | 553.4M | 581.1M | |
Property Plant And Equipment Gross | 3.1M | 12.1M | 12.8M | 15.3M | 33.1M | 34.8M | |
Total Current Assets | 132.4M | 190.2M | 258.5M | 433.9M | 640.4M | 672.4M | |
Accumulated Other Comprehensive Income | (150.4M) | 1K | (93K) | 501K | 2.8M | 3.0M | |
Net Working Capital | 96.3M | 112.4M | 159.7M | 274.3M | 454.5M | 477.2M | |
Intangible Assets | 2.4M | 1.2M | 599K | 99K | 89.1K | 84.6K | |
Property Plant Equipment | 3.1M | 3.4M | 12.8M | 8.4M | 9.6M | 5.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Progyny offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Progyny's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Progyny Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Progyny Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Progyny Stock analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Progyny's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Progyny. If investors know Progyny will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Progyny listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 0.61 | Revenue Per Share 11.583 | Quarterly Revenue Growth 0.076 | Return On Assets 0.0569 |
The market value of Progyny is measured differently than its book value, which is the value of Progyny that is recorded on the company's balance sheet. Investors also form their own opinion of Progyny's value that differs from its market value or its book value, called intrinsic value, which is Progyny's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progyny's market value can be influenced by many factors that don't directly affect Progyny's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Progyny's value and its price as these two are different measures arrived at by different means. Investors typically determine if Progyny is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progyny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.